Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2001-04-27
2003-12-09
Raymond, Richard L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S578000
Reexamination Certificate
active
06660730
ABSTRACT:
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to anhydrous mirtazapine and a process for preparing the same.
2. Discussion of the Background
U.S. Pat. No. 4,062,848 discloses a process for increasing the purity of mirtazapine, (a useful antidepressant), by recrystallizing mirtazapine from a petroleum ether or similar subject.
However, in performing this process, impurities are precipitated in an oily state when crude mirtazapine having a purity of about 95 to 99% is used, so that the crystallization of mirtazapine is inhibited, and makes it difficult to crystallize mirtazapine having a high purity.
Accordingly, there is a significant need for a process capable of efficiently and industrially preparing anhydrous mirtazapine having a high purity from crude mirtazapine.
SUMMARY OF THE INVENTION
Accordingly, one object of the present invention is to provide a process capable of efficiently preparing an anhydrous mirtazapine crystal substantially free of lower alcohol insolubles.
A further object of the present invention is to provide a method for the production of anhydrous mirtazapine having an average particle diameter of 10 to 50 &mgr;m and substantially free of residual solvent.
These and other objects of the present invention have been satisfied by the discovery of a process for preparing an anhydrous mirtazapine crystal, comprising filtering a lower alcohol solution of crude mirtazapine to provide a filtrate; concentrating the filtrate to provide a concentrated filtrate; and crystallizing anhydrous mirtazapine from the concentrated filtrate using a precipitation solvent selected from the group consisting of heptane and petroleum ethers and the anhydrous mirtazapine crystal produced thereby which is substantially free of lower alcohol insolubles.
In a further embodiment, the present invention relates to the discovery of a process for the production of anhydrous mirtazapine crystal that is substantially free of residual solvent, by pulverizing the anhydrous mirtazapine to an average particle diameter of from 10 to 50 &mgr;m, and the anhydrous mirtazapine crystal produced thereby.
REFERENCES:
patent: 4062848 (1977-12-01), Van Der Burg
patent: WO 00/62782 (2000-10-01), None
Iishi Eiichi
Maeda Chiharu
Yoshikawa Sadanobu
Liu Hong
Oblon & Spivak, McClelland, Maier & Neustadt P.C.
Raymond Richard L.
Sumika Fine Chemicals Co., Ltd.
LandOfFree
Anhydrous mirtazapine and process for preparing the same does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anhydrous mirtazapine and process for preparing the same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anhydrous mirtazapine and process for preparing the same will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3130146